Literature DB >> 27497277

Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.

Gyohei Egawa1, Kenji Kabashima2.   

Abstract

Atopic dermatitis (AD) is the most common inflammatory skin disease in the industrialized world and has multiple causes. Over the past decade, data from both experimental models and patients have highlighted the primary pathogenic role of skin barrier deficiency in patients with AD. Increased access of environmental agents into the skin results in chronic inflammation and contributes to the systemic "atopic (allergic) march." In addition, persistent skin inflammation further attenuates skin barrier function, resulting in a positive feedback loop between the skin epithelium and the immune system that drives pathology. Understanding the mechanisms of skin barrier maintenance is essential for improving management of AD and limiting downstream atopic manifestations. In this article we review the latest developments in our understanding of the pathomechanisms of skin barrier deficiency, with a particular focus on the formation of the stratum corneum, the outermost layer of the skin, which contributes significantly to skin barrier function.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; barrier function; corneocytes; cornified envelope; filaggrin; lipid; stratum corneum; tight junction

Mesh:

Substances:

Year:  2016        PMID: 27497277     DOI: 10.1016/j.jaci.2016.06.002

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  43 in total

1.  Pathophysiology of atopic dermatitis: Clinical implications.

Authors:  Jihyun Kim; Byung Eui Kim; Donald Y M Leung
Journal:  Allergy Asthma Proc       Date:  2019-03-01       Impact factor: 2.587

Review 2.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

Review 3.  The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.

Authors:  Yvonne J Huang; Benjamin J Marsland; Supinda Bunyavanich; Liam O'Mahony; Donald Y M Leung; Antonella Muraro; Thomas A Fleisher
Journal:  J Allergy Clin Immunol       Date:  2017-02-28       Impact factor: 10.793

Review 4.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

Review 5.  The Therapeutic Role of ADSC-EVs in Skin Regeneration.

Authors:  Yixi Wang; Lihui Cheng; Hanxing Zhao; Zhengyong Li; Junjie Chen; Ying Cen; Zhenyu Zhang
Journal:  Front Med (Lausanne)       Date:  2022-06-09

6.  Effect of 6,7-dimethoxy-2,2-dimethyl-2H-chromene (agerarin) on the recovery of filaggrin expression through targeting of Janus kinases in the inflammatory skin.

Authors:  Sung Shin Ahn; Young Han Lee; Hyunjin Yeo; Youngshim Lee; Do Sik Min; Yoongho Lim; Soon Young Shin
Journal:  J Food Drug Anal       Date:  2020-09-15       Impact factor: 6.157

7.  Contribution of an impaired epithelial barrier to the atopic march.

Authors:  Elisabet Johansson; Gurjit K Khurana Hershey
Journal:  Ann Allergy Asthma Immunol       Date:  2018-02       Impact factor: 6.347

8.  IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.

Authors:  Achilleas Floudas; Sean P Saunders; Tara Moran; Christian Schwartz; Emily Hams; Denise C Fitzgerald; James A Johnston; Graham S Ogg; Andrew N McKenzie; Patrick T Walsh; Padraic G Fallon
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

9.  Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Authors:  Calum T Robb; Henry J McSorley; Jinju Lee; Tomohiro Aoki; Cunjing Yu; Siobhan Crittenden; Anne Astier; Jennifer M Felton; Nicholas Parkinson; Adane Ayele; Richard M Breyer; Stephen M Anderton; Shuh Narumiya; Adriano G Rossi; Sarah E Howie; Emma Guttman-Yassky; Richard B Weller; Chengcan Yao
Journal:  J Allergy Clin Immunol       Date:  2017-06-03       Impact factor: 10.793

Review 10.  Clinical approach to the patient with refractory atopic dermatitis.

Authors:  Neema Izadi; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.